- Home
- OVBC vs NTHI Comparison
OVBC vs NTHI Comparison
Compare OVBC & NTHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OVBC
- NTHI
- Stock Information
- Founded
- OVBC 1872
- NTHI 2008
- Country
- OVBC United States
- NTHI United States
- Employees
- OVBC N/A
- NTHI N/A
- Industry
- OVBC Major Banks
- NTHI Biotechnology: Pharmaceutical Preparations
- Sector
- OVBC Finance
- NTHI Health Care
- Exchange
- OVBC Nasdaq
- NTHI Nasdaq
- Market Cap
- OVBC 149.1M
- NTHI 142.5M
- IPO Year
- OVBC N/A
- NTHI N/A
- Fundamental
- Price
- OVBC $31.65
- NTHI $4.26
- Analyst Decision
- OVBC
- NTHI
- Analyst Count
- OVBC 0
- NTHI 0
- Target Price
- OVBC N/A
- NTHI N/A
- AVG Volume (30 Days)
- OVBC 7.6K
- NTHI 24.1K
- Earning Date
- OVBC 07-25-2025
- NTHI 01-01-0001
- Dividend Yield
- OVBC 3.13%
- NTHI N/A
- EPS Growth
- OVBC 10.90
- NTHI N/A
- EPS
- OVBC 2.67
- NTHI N/A
- Revenue
- OVBC $61,741,000.00
- NTHI $79,990.00
- Revenue This Year
- OVBC N/A
- NTHI N/A
- Revenue Next Year
- OVBC N/A
- NTHI N/A
- P/E Ratio
- OVBC $10.98
- NTHI N/A
- Revenue Growth
- OVBC 10.84
- NTHI 13.52
- 52 Week Low
- OVBC $19.35
- NTHI $4.11
- 52 Week High
- OVBC $40.99
- NTHI $25.00
- Technical
- Relative Strength Index (RSI)
- OVBC 40.47
- NTHI N/A
- Support Level
- OVBC $30.99
- NTHI N/A
- Resistance Level
- OVBC $34.50
- NTHI N/A
- Average True Range (ATR)
- OVBC 1.25
- NTHI 0.00
- MACD
- OVBC -0.13
- NTHI 0.00
- Stochastic Oscillator
- OVBC 16.46
- NTHI 0.00
About OVBC Ohio Valley Banc Corp.
Ohio Valley Banc Corporation is a financial holding company. The bank is a full-service financial institution offering a blend of commercial and consumer banking services within Southeastern Ohio as well as western West Virginia. The banking services offered by the bank include the acceptance of deposits in checking, savings, time and money market accounts; the making and servicing of personal, commercial, and student loans; and the making of construction and real estate loans. It also offers individual retirement accounts, safe deposit boxes, wire transfers and other standard banking products and services.
About NTHI NeOnc Technologies Holdings Inc. Common Stock
NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration ("FDA").